SMFM recently updated guidance on the administration of antenatal corticosteroids in the late preterm period. We will indicate the best available data for counseling patients. This week we have the fantastic Nancy Chescheir, MD, FACOG as our moderator. Dr. Chescheir is a clinical professor of Obstetrics and Gynecology and a Maternal-Fetal Medicine Specialist. Her primary interests are in global women’s health, fetal disorders, and high order multiple gestations. She has served in multiple administrative roles, including the chair of obstetrics and gynecology at Vanderbilt University School of Medicine, acting chair at UNC School of Medicine, Associate Dean for the Curriculum at UNC, Chief of Staff at Bokamoso Private Hospital in Botswana, and Scientific Program Director for the NICHD Randomized Controlled Trial of in utero v standard repair of fetal myelomeningocele. 

Today we talk with Luciana Vieira, MD about Antenatal Late Preterm Steroids and understanding the new practice guidelines as well as how they impact care. In our discussion, we touch upon how to describe and assess indications and exclusions for late preterm steroid administration, review evidence supporting the use of antenatal corticosteroid use in the late preterm period, and describe known benefits and limitations of late preterm steroid administration. We also describe considerations for counseling patients about risks, benefits, and unknowns of late preterm use